Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02621840 · ClinicalTrials.gov registry record · NA
A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation
A NA study, sponsored by Wills Eye.
- Completed
- Registry status
- NA
- Development phase
- 442
- Enrollment target
NCT02621840: Completed NA study, sponsored by Wills Eye.
NCT02621840 is a NA study that has completed, run by Wills Eye. The registered enrollment target is 442 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02621840, a NA study, has completed, sponsored by Wills Eye.
- COMPLETED
- Registry status
- NA
- Development phase
- 442 participants
- Enrollment target
Study Summary
The investigators aim to investigate the impact of mandating on-site pre-admission testing on cataract cancellation rates in a randomized, prospective, intervention study. Cataract extraction is the most commonly performed ocular surgery making surgical training an integral component of ophthalmology residency. Patient cancellation of surgery results in a financial burden to the institution and a loss of essential educational experiences for the residents. An earlier study explored variables impacting cancellation rates and identified incomplete pre-admission testing as a major contributing factor to surgery cancellation. Patients will be randomized to either 1) the intervention group where on-site pre-admission testing will be mandated or 2) the control group, where on-site pre-admission testing will be offered but not mandated. Cancellation rates will be collected prospectively and statistical analysis utilized to evaluate the significance of intervention.
Primary Outcome
The adherence rate to cataract surgery will be assessed in the usual care and intervention groups and compared.
Interventions
- BEHAVIORAL Mandatory On-Site Pre-Admission Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 442 participants |
| Start Date | 2015-01 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02621840 record still lists
NCT02621840 is an interventional study that assigns participants to a tested intervention. The registered 442 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 1 intervention - of which Mandatory On-Site Pre-Admission Testing is the first listed.
NCT02621840 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02621840 about?
NCT02621840 is a clinical study titled "A Proposed Intervention to Decrease Resident-Performed Cataract Surgery Cancellation". The investigators aim to investigate the impact of mandating on-site pre-admission testing on cataract cancellation rates in a randomized, prospective, intervention study. Cataract extraction is the most commonly performed ocular surgery making surgical training an integral component of ophthalmolog...
What is the current status of trial NCT02621840?
This trial is currently completed. It is a NA study. The enrollment target is 442 participants. The study started on 2015-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02621840?
The interventions under investigation include: Mandatory On-Site Pre-Admission Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02621840?
This trial is sponsored by Wills Eye, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02621840's enrollment target sits among peer trials
442 233rd of 2000 higher than 1,768 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704766 · 442 participants · NA
Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
- NCT04657068 · 442 participants · Phase 1
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- NCT05410145 · 442 participants · Phase 1
A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation
- NCT06659029 · 442 participants
Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia